Valuation Gilead Sciences, Inc. Deutsche Boerse AG

Stocks

Market Closed - Deutsche Boerse AG 08:38:48 15/09/2026 pm IST			Pre-market 10:53:45 am
125.10 ^EUR	+0.87%		126.91	+1.45%

15/09	Gilead Sciences, Inc. and Pan American Health Organization Announce Milestone Partnership to Accelerate Access to Twice-Yearly Lenacapavir for HIV Prevention Across Latin America and the Caribbean	CI
15/09	Gilead Sciences, Inc. Presents at Morgan Stanley 24th Annual Global Healthcare Conference, Sep-15-2026 10:45 AM

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	91,081	1,07,677	1,00,942	1,15,118	1,52,281	1,81,405	-	-
Change	-	18.22%	-6.25%	14.04%	32.28%	19.13%	-	-
Enterprise Value (EV) ¹	1,18,530	1,26,522	1,18,665	1,31,838	1,69,585	1,98,151	1,90,530	1,84,240
Change	-	6.74%	-6.21%	11.1%	28.63%	16.84%	-3.85%	-3.3%
P/E	14.7x	23.6x	18x	243x	18.1x	-44.2x	18.2x	16.8x
PBR	4.32x	5.05x	4.48x	5.98x	6.73x	10.9x	8.04x	6.29x
PEG	-	-0.9x	0.8x	-2.7x	0x	0x	-0x	1.97x
Capitalization / Revenue	3.34x	3.95x	3.72x	4x	5.17x	5.91x	5.55x	5.28x
EV / Revenue	4.34x	4.64x	4.38x	4.59x	5.76x	6.45x	5.83x	5.36x
EV / EBITDA	8.12x	8.86x	9.01x	11.7x	10.6x	25.2x	10.7x	10.1x
EV / EBIT	9.45x	10.4x	11.3x	15.5x	12.9x	61.2x	12x	10.9x
EV / FCF	11x	15.2x	16x	12.8x	17.9x	-376x	14.6x	13.3x
FCF Yield	9.12%	6.59%	6.25%	7.82%	5.58%	-0.27%	6.86%	7.53%
Dividend per Share ²	2.84	2.92	3	3.08	3.16	3.291	3.349	3.012
Rate of return	3.91%	3.4%	3.7%	3.33%	2.57%	2.25%	2.29%	2.06%
EPS ²	4.93	3.64	4.5	0.38	6.78	-3.306	8.024	8.707
Distribution rate	57.6%	80.2%	66.7%	811%	46.6%	-99.5%	41.7%	34.6%
Net sales ¹	27,305	27,281	27,116	28,754	29,443	30,702	32,682	34,347
EBITDA ¹	14,598	14,283	13,177	11,287	15,953	7,859	17,834	18,324
EBIT ¹	12,548	12,180	10,484	8,520	13,193	3,240	15,834	16,889
Net income ¹	6,225	4,592	5,665	480	8,510	-4,275	10,275	10,917
Net Debt ¹	27,449	18,845	17,723	16,720	17,304	16,745	9,125	2,835
Reference price ²	72.61	85.85	81.01	92.37	122.74	146.30	146.30	146.30
Nbr of stocks (in thousands)	12,54,384	12,54,244	12,46,042	12,46,266	12,40,680	12,39,955	-	-
Announcement Date	01/02/22	02/02/23	06/02/24	11/02/25	10/02/26	-	-	-

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
ELI LILLY AND COMPANY	32.41x	11.77x	23.88x	0.61%	1,01300Cr
JOHNSON & JOHNSON	29.62x	6.59x	18.45x	2.02%	64TCr
ABBVIE INC.	33.52x	7.76x	16.03x	2.62%	46TCr
ROCHE HOLDING AG	19.65x	4.78x	11.85x	2.77%	35TCr
NOVARTIS AG	19.69x	5.14x	12.76x	3.13%	26TCr
ASTRAZENECA PLC	21.05x	4.32x	12.35x	2.04%	25TCr
AMGEN INC.	24.13x	6.36x	11.33x	2.64%	20TCr
NOVO NORDISK A/S	12.48x	4.54x	9.49x	4.03%	19TCr
GILEAD SCIENCES, INC.	-44.28x	6.46x	25.23x	2.25%	18TCr
Average	16.47x	6.41x	15.71x	2.46%	39.6TCr
Weighted average by Cap.	23.61x	7.64x	17.63x	2.01%